101
|
Lopez-Gordo MA, Fernandez E, Romero S, Pelayo F, Prieto A. An auditory brain–computer interface evoked by natural speech. J Neural Eng 2012; 9:036013. [PMID: 22626956 DOI: 10.1088/1741-2560/9/3/036013] [Citation(s) in RCA: 34] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Brain–computer interfaces (BCIs) are mainly intended for people unable to perform any muscular movement, such as patients in a complete locked-in state. The majority of BCIs interact visually with the user, either in the form of stimulation or biofeedback. However, visual BCIs challenge their ultimate use because they require the subjects to gaze, explore and shift eye-gaze using their muscles, thus excluding patients in a complete locked-in state or under the condition of the unresponsive wakefulness syndrome. In this study, we present a novel fully auditory EEG-BCI based on a dichotic listening paradigm using human voice for stimulation. This interface has been evaluated with healthy volunteers, achieving an average information transmission rate of 1.5 bits min⁻¹ in full-length trials and 2.7 bits min⁻¹ using the optimal length of trials, recorded with only one channel and without formal training. This novel technique opens the door to a more natural communication with users unable to use visual BCIs, with promising results in terms of performance, usability, training and cognitive effort.
Collapse
|
102
|
Zaninovic N, Rosenwaks Z, Iager AE, Kocabas AM, Otu HH, Ruppel P, Langerveld A, Schnarr P, Suarez M, Jarrett JC, Conaghan J, Rosa GJM, Fernandez E, Rawlins RG, Cibelli JB, Crosby J, Kirkegaard K, Hindkjaer J, Ingerslev HJ, Lykke-Hartmann K, Himaya E, Jamal W, Phillips S, Delrieu D, Hamamah S, Kadoch IJ, Cortezzi SS, Cabral EC, Ferreira CR, Trevisan MG, Figueira RCS, Eberlin MN, Iaconelli A, Borges E, Chimote NM, Chimote NN, Nath NM, Chimote MN, Mehta BN. SESSION 02: EMBRYOLOGY - BIOMARKERS. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.2] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
103
|
Martin J, Fernandez E, Estay J, Gordan VV, Mjor IA, Moncada G. Minimal invasive treatment for defective restorations: five-year results using sealants. Oper Dent 2012; 38:125-33. [PMID: 22788726 DOI: 10.2341/12-062c] [Citation(s) in RCA: 30] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
Abstract
Replacement of dental restorations has been the traditional treatment for restorations that are defective. In this five-year randomized clinical trial, restorations with localized marginal defects were treated with sealants. Thirty-two patients (mean age, 26.8 years) with 126 Class I and Class II restorations with defective margins (amalgam n=69 and resin-based composite n=57) were recruited. Treatment was seal with pit and fissure sealant on localized marginal defects (group A: n=43) and was compared with total restoration replacement (group B: n=40) and untreated restorations (group C: n=43) as negative and positive controls. Restorations were assessed by two examiners using the modified US Public Health Service criteria, observing five clinical parameters: marginal adaptation, roughness, marginal stain, teeth sensitivity, and secondary caries at baseline and at five years after treatment. At the five-year recall examination, 23 patients with 90 restorations (71.4% recall rate) were examined. A significant improvement was observed in the marginal adaptation of the restorations in group A compared with group B. None of the treated group showed trends to downgrade in any parameter. Tooth sensitivity and secondary caries showed a low frequency in all groups. No significant difference in marginal adaptation of the restorations was found between amalgam and resin-based composite restorations (p=0.191). This study demonstrated that marginal sealing of restorations is a minimally invasive treatment that may be used instead of the replacement of restorations with localized marginal defects.
Collapse
|
104
|
Agnes H, Kalman P, Jozsef A, Henrik B, Mucsi I, Kamata K, Sano T, Naito S, Okamoto T, Okina C, Kamata M, Murano J, Kobayashi K, Uchida M, Aoyama T, Takeuchi Y, Nagaba Y, Sakamoto H, Torino C, Torino C, Panuccio V, Clementi A, Garozzo M, Bonanno G, Boito R, Natale G, Cicchetti T, Chippari A, Logozzo D, Alati G, Cassani S, Sellaro A, D'arrigo G, Tripepi G, Roberta A, Postorino M, Mallamaci F, Zoccali C, Buonanno E, Brancaccio S, Fimiani V, Napolitano P, Spadola R, Morrone L, DI Iorio B, Russo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso J, Fernandez E, Bernadette F, Jean-Baptiste B, Frimat L, Madala ND, Thusi GP, Sibisi N, Mazibuko BG, Assounga AGH, Tsai NC, Wang HH, Chen YC, Hung CC, Hwang SJ, Chen HC, Branco P, Adragao T, Birne R, Martins AR, Vizinho R, Gaspar A, Grilo MJ, Barata JD, Bonhorst D, Adragao P, Kim JS, Yang JW, Kim MK, Choi SO, Han BG, Nathalie N, Sunny E, Glorieux G, Daniela B, Fellype B, Sophie L, Horst D L, Ziad M, Raymond V, Yanai M, Okada K, Takeuchi K, Nitta K, Takahashi S, Morena M, Jaussent I, Halkovich A, Dupuy AM, Bargnoux AS, Chenine L, Leray-Moragues H, Klouche K, Vernhet H, Canaud B, Cristol JP, Shutov A, Serov V, Kuznetsova J, Menzorov M, Serova D, Petrescu L, Zugravu A, Capusa C, Stancu S, Cinca S, Anghel C, Timofte D, Medrihan L, Ionescu D, Mircescu G, Hsu TW, Kuo KL, Hung SC, Tarng DC, Lee S, Kim I, Lee D, Rhee H, Song S, Seong E, Kwak I, Holzmann M, Gardell C, Jeppsson A, Sartipy U, Solak Y, Yilmaz MI, Caglar K, Saglam M, Yaman H, Sonmez A, Unal HU, Gok M, Gaipov A, Kayrak M, Eyileten T, Turk S, Vural A, DI Lullo L, Floccari F, Rivera R, Granata A, D'amelio A, Logias F, Otranto G, Malaguti M, Santoboni A, Fiorini F, Connor T, Oygar D, Nitsch D, Gale D, Steenkamp R, Neild GH, Maxwell P, Louise Hogsbro I, Redal-Baigorri B, Sautenet B, Halimi JM, Caille A, Goupille P, Giraudeau B, Solak Y, Yilmaz MI, Caglar K, Saglam M, Yaman H, Unal HU, Gok M, Oguz Y, Gaipov A, Yenicesu M, Cetinkaya H, Eyileten T, Turk S, Vural A, Chen YC, Wang HH, Tsai NC, Hung CC, Hwang SJ, Chen HC, Ishimoto Y, Ohki T, Sugahara M, Kanemitsu T, Kobayashi M, Uchida L, Kotera N, Tanaka S, Sugimoto T, Mise N, Miyazaki N, Matsumoto J, Murata I, Yoshida G, Morishita K, Ushikoshi H, Nishigaki K, Ogura S, Minatoguchi S, Harvey R, Harvey R, Ala A, Banerjee D, Farmer C, Irving J, Hobbs H, Wheeler T, Klebe B, Stevens P, Selim G, Selim G, Stojceva-Taneva O, Tozija L, Stojcev N, Gelev S, Dzekova-Vidimliski P, Pavleska S, Sikole A, Qureshi AR, Evans M, Stendahl M, Prutz KG, Elinder CG, Tamagaki K, Kado H, Nakata M, Kitani T, Ota N, Ishida R, Matsuoka E, Shiotsu Y, Ishida M, Mori Y, Christelle M, Rognant N, Evelyne D, Sophie F, Laurent J, Maurice L, Silverwood R, Pierce M, Kuh D, Savage C, Ferro C, Nitsch D, Moniek DG, De Goeij M, Nynke H, Gurbey O, Joris R, Friedo D, Clayton P, Grace B, Cass A, Mcdonald S, Lorenzo V, Martin Conde M, Betriu A, Dusso A, Valdivielso JM, Fernandez E, Roggeri DP, Cannella G, Cozzolino M, Mazzaferro S, Messa P, Brancaccio D, De Souza Faria R, Fernandes N, Lovisi J, Moura Marta M, Reboredo M, Do Vale Pinheiro B, Bastos M, Hundt F, Hundt F, Pabst S, Hammerstingl C, Gerhardt T, Skowasch D, Woitas R, Lopes AA, Silva LF, Matos CM, Martins MS, Silva FA, Lopes GB, Pizzarelli F, Dattolo P, Tripepi G, Michelassi S, Rossi C, Bandinelli S, Mieth M, Mass R, Ferrucci L, Zoccali C, Parisi S, Arduino S, Attini R, Fassio F, Biolcati M, Pagano A, Bossotti C, Ferraresi M, Gaglioti P, Todros T, Piccoli GB, Salgado TM, Arguello B, Benrimoj SI, Fernandez-Llimos F, Bailey P, Tomson C, Ben-Shlomo Y, Santoro A, Rucci P, Mandreoli M, Caruso F, Corradini M, Flachi M, Gibertoni D, Rigotti A, Russo G, Fantini M, Mahapatra HS, Choudhury S, Buxi G, Sharma N, Gupta Y, Sekhar V, Mahapatra HS, Choudhury S, Buxi G, Sharma N, Gupta Y, Sekhar V, Yanagisawa N, Ando M, Ajisawa A, Tsuchiya K, Nitta K, Janusz O, Mikolaj M, Jacek M, Boleslaw R, Prakash S, Coffin R, Schold J, Einstadter D, Stark S, Rodgers D, Howard M, Sehgal A, Stevens P, Irving J, Wheeler T, Klebe B, Farmer C, Palmer S, Tong A, Manns B, Craig J, Ruospo M, Gargano L, Strippoli G, Ruospo M, Palmer S, Vecchio M, Gargano L, Petruzzi M, De Benedictis M, Pellegrini F, Strippoli G, Ohno Y, Ishimura E, Naganuma T, Kondo K, Fukushima W, Mui K, Inaba M, Hirota Y, Sun X, Sun X, Jiang S, Gu H, Chen Y, XI C, Qiao X, Chen X, Daher E, Junior GS, Jacinto CN, Pimentel RS, Aguiar GBR, Lima CB, Borges RC, Mota LPC, Melo JVL, Melo SA, Canamary VT, Alves M, Araujo SMHA, Chen YC, Hung CC, Huang YK, Tsai NC, Wang HH, Hung CC, Hwang SJ, Chen HC, Rogacev K, Cremers B, Zawada A, Seiler S, Binder N, Ege P, Grosse-Dunker G, Heisel I, Hornof F, Jeken J, Rebling N, Ulrich C, Scheller B, Bohm M, Fliser D, Heine GH, Robinson B, Wang M, Bieber B, Fluck R, Kerr PG, Wikstrom B, Krishnan M, Nissenson A, Pisoni RL, Mykleset S, Osthus TB, Waldum B, Os I, Buttigieg J, Buttigieg J, Cassar A, Farrugia Agius J, Redal-Baigorri B, Hara M, Ando M, Tsuchiya K, Nitta K, Yamato M, Yasuda K, Sasaki K. Clinical Nephrology - Epidemiology II. Nephrol Dial Transplant 2012. [DOI: 10.1093/ndt/gfs236] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
105
|
Luigetti M, Sabatelli M, Montano N, Cianfoni A, Fernandez E, Lo Monaco M. Teaching neuroimages: Peroneal intraneural ganglion cyst: a rare cause of drop foot in a child. Neurology 2012; 78:e46-7. [PMID: 22330419 DOI: 10.1212/wnl.0b013e318246d6e9] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
106
|
Martínez C, Fernandez E. 33 The Global Network for Tobacco Free Health Care Services: Transferable Concept and Tools for Tobacco Control – Example of 17 National/Regional Members. Eur J Oncol Nurs 2012. [DOI: 10.1016/s1462-3889(12)70048-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
107
|
Rodriguez-Rodriguez P, Fernandez E, Almeida A, Bolaños JP. Excitotoxic stimulus stabilizes PFKFB3 causing pentose-phosphate pathway to glycolysis switch and neurodegeneration. Cell Death Differ 2012; 19:1582-9. [PMID: 22421967 PMCID: PMC3438489 DOI: 10.1038/cdd.2012.33] [Citation(s) in RCA: 86] [Impact Index Per Article: 7.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022] Open
Abstract
6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) is a master regulator of glycolysis by its ability to synthesize fructose-2,6-bisphosphate, a potent allosteric activator of 6-phosphofructo-1-kinase. Being a substrate of the E3 ubiquitin ligase anaphase-promoting complex-Cdh1 (APCCdh1), PFKFB3 is targeted to proteasomal degradation in neurons. Here, we show that activation of N-methyl-D-aspartate subtype of glutamate receptors (NMDAR) stabilized PFKFB3 protein in cortical neurons. Expressed PFKFB3 was found to be mainly localized in the nucleus, where it is subjected to degradation; however, expression of PFKFB3 lacking the APCCdh1-targeting KEN motif, or following NMDAR stimulation, promoted accumulation of PFKFB3 and its release from the nucleus to the cytosol through an excess Cdh1-inhibitable process. NMDAR-mediated increase in PFKFB3 yielded neurons having a higher glycolysis and lower pentose-phosphate pathway (PPP); this led to oxidative stress and apoptotic neuronal death that was counteracted by overexpressing glucose-6-phosphate dehydrogenase, the rate-limiting enzyme of the PPP. Furthermore, expression of the mutant form of PFKFB3 lacking the KEN motif was sufficient to trigger oxidative stress and apoptotic death of neurons. These results reveal that, by inhibition of APCCdh1, glutamate receptors activation stabilizes PFKFB3 thus switching neuronal metabolism leading to oxidative damage and neurodegeneration.
Collapse
|
108
|
Kirov G, Pocklington AJ, Holmans P, Ivanov D, Ikeda M, Ruderfer D, Moran J, Chambert K, Toncheva D, Georgieva L, Grozeva D, Fjodorova M, Wollerton R, Rees E, Nikolov I, van de Lagemaat LN, Bayés À, Fernandez E, Olason PI, Böttcher Y, Komiyama NH, Collins MO, Choudhary J, Stefansson K, Stefansson H, Grant SGN, Purcell S, Sklar P, O'Donovan MC, Owen MJ. De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia. Mol Psychiatry 2012; 17:142-53. [PMID: 22083728 PMCID: PMC3603134 DOI: 10.1038/mp.2011.154] [Citation(s) in RCA: 617] [Impact Index Per Article: 51.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
A small number of rare, recurrent genomic copy number variants (CNVs) are known to substantially increase susceptibility to schizophrenia. As a consequence of the low fecundity in people with schizophrenia and other neurodevelopmental phenotypes to which these CNVs contribute, CNVs with large effects on risk are likely to be rapidly removed from the population by natural selection. Accordingly, such CNVs must frequently occur as recurrent de novo mutations. In a sample of 662 schizophrenia proband-parent trios, we found that rare de novo CNV mutations were significantly more frequent in cases (5.1% all cases, 5.5% family history negative) compared with 2.2% among 2623 controls, confirming the involvement of de novo CNVs in the pathogenesis of schizophrenia. Eight de novo CNVs occurred at four known schizophrenia loci (3q29, 15q11.2, 15q13.3 and 16p11.2). De novo CNVs of known pathogenic significance in other genomic disorders were also observed, including deletion at the TAR (thrombocytopenia absent radius) region on 1q21.1 and duplication at the WBS (Williams-Beuren syndrome) region at 7q11.23. Multiple de novos spanned genes encoding members of the DLG (discs large) family of membrane-associated guanylate kinases (MAGUKs) that are components of the postsynaptic density (PSD). Two de novos also affected EHMT1, a histone methyl transferase known to directly regulate DLG family members. Using a systems biology approach and merging novel CNV and proteomics data sets, systematic analysis of synaptic protein complexes showed that, compared with control CNVs, case de novos were significantly enriched for the PSD proteome (P=1.72 × 10⁻⁶. This was largely explained by enrichment for members of the N-methyl-D-aspartate receptor (NMDAR) (P=4.24 × 10⁻⁶) and neuronal activity-regulated cytoskeleton-associated protein (ARC) (P=3.78 × 10⁻⁸) postsynaptic signalling complexes. In an analysis of 18 492 subjects (7907 cases and 10 585 controls), case CNVs were enriched for members of the NMDAR complex (P=0.0015) but not ARC (P=0.14). Our data indicate that defects in NMDAR postsynaptic signalling and, possibly, ARC complexes, which are known to be important in synaptic plasticity and cognition, play a significant role in the pathogenesis of schizophrenia.
Collapse
|
109
|
Salvà A, Andrieu S, Fernandez E, Schiffrin EJ, Moulin J, Decarli B, Rojano-i-Luque X, Guigoz Y, Vellas B. Health and nutrition promotion program for patients with dementia (NutriAlz): cluster randomized trial. J Nutr Health Aging 2011; 15:822-30. [PMID: 22159768 DOI: 10.1007/s12603-011-0363-3] [Citation(s) in RCA: 52] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
Abstract
OBJECTIVE To assess the effectiveness of health and nutrition program (NutriAlz) versus usual care on functional level in elderly people with dementia living at home, as well as on clinical practice related to nutrition and on the caregiver's burden. DESIGN Cluster randomized multi-centre study with one-year follow-up. SETTING 11 Alzheimer outpatients and day care centres (Barcelona, Spain). PARTICIPANTS Nine hundred and forty six home-living Alzheimer patients with identified caregiver were consecutively recruited (intervention group: 6 centres, 448 patients vs control group: 5 centres, 498 patients). INTERVENTION The intervention was a teaching and training intervention on health and nutrition program, NutriAlz, directed both to physician and main caregiver, as well as persons affected by Alzheimer's disease or other dementias, including a standardised protocol for feeding and nutrition. MAIN OUTCOME MEASURES The main outcome measure was the reduction in the loss of autonomy (Activities of daily living (ADL/IADL) scales) assessed at 6 and 12 months. Secondary outcomes measures were Improvement in nutritional status (Mini Nutritional Assessment (MNA), BMI, and weight changes), and caregiver burden (Zarit scale). RESULTS The one-year assessment was completed for 293 patients (65.4%) in the intervention group and 363 patients (72.9%) in the control group (usual care). The annual rate of ADL change was -0.83 vs -0.62 (p=0.984), and the caregiver's subjective burden 0.59 vs 2.36 (p=0.681) in intervention and control group, respectively. MNA, however, showed an improvement (+0.46 vs -0.66, p=0.028), suggesting an effective nutritional behaviour. CONCLUSION The NutriAlz program had no effect on functional decline in Alzheimer disease patients living at home over one year, but reduced the risk for malnutrition, as recommendations concerning diet and exercise were provided.
Collapse
|
110
|
Martinez-Sanchez JM, Gallus S, Zuccaro P, Colombo P, Fernandez E, Manzari M, La Vecchia C. Exposure to secondhand smoke in Italian non-smokers 5 years after the Italian smoking ban. Eur J Public Health 2011; 22:707-12. [DOI: 10.1093/eurpub/ckr156] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
111
|
Pradera JF, Salvador J, Grilo A, Rodriguez M, Lopez A, Bernabe R, Fernandez E, Gallego I, Morales D. Abstract A9: Chronology of arterial hypertension and microalbuminuria associated with inhibiting treatments of vascular endothelium growth factor receptor in patients with cancer. Mol Cancer Ther 2011. [DOI: 10.1158/1535-7163.targ-11-a9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Purpose: Angiogenesis plays a major role in cancer. Drugs blocking the growth factor receptor in the vascular endothelium constitute a fundamental treatment in several cancers. Hypertension (HBP) and proteinuria associated with these treatments is frequent and presents in an oscillating and irregular way and is generally controlled by scarcely reliable means. Methods: We started a prospective study with the determination of microalbuminuria (MAL) in 24 hours orine samples and the execution of pre- and post-treatment 24 h-ambulatory blood pressure monitoring (ABPM) and selfmeasured of BP every 12 hours at home, during 60 days, in patients with cancer under treatment with either bevacizumab or sunitinib with a view to identifying the variations in MAL, ABPM and the onset of HBP at an early stage. For ABPM, a validated recording device was used; a recording was made prior to the start of the anti-angiogenic treatment and 20 days (at least) after the first dose. An OMRON M6 tensiometer validated by the European HBP Society was used, with the ambulatory BP figures being collected at home as per standards. MAL was measured in 24h orine samples in mg/L and mg/gr creatinine. The primary goal is to find differences of at least 16 mmHg in the mean BP between the two ABPM readings. Results: N=21. Eighteen patients received bevacizumab and three sunitinib. Mean age 57.0 years (26–79). Three patients was known to be hypertensive. Differences of 4.9 and 3.9 mmHg were found between the mean systolic and diastolic BPs before and after treatment (p<0.05). Conclusions: Our data revealed a statically significant increase of blood pressure in patients treated with antiangiongenics as determined by ABMP. The data point to a greater increase in nocturnal BP suggesting a non-dipper pattern. The self measured records shown an early onset HBP. Microalbuminuria trends to increase in this patients. All data will be shown at the meeting.
Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the AACR-NCI-EORTC International Conference: Molecular Targets and Cancer Therapeutics; 2011 Nov 12-16; San Francisco, CA. Philadelphia (PA): AACR; Mol Cancer Ther 2011;10(11 Suppl):Abstract nr A9.
Collapse
|
112
|
Mantz C, Fernandez E, Zucker I, Harrison S. A Phase II Trial of Real-time Target Tracking SBRT for Low-risk Prostate Cancer Utilizing the Calypso 4D Localization System: Patient-reported Quality of Life and Toxicity Outcomes. Int J Radiat Oncol Biol Phys 2011. [DOI: 10.1016/j.ijrobp.2011.06.203] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
113
|
Fernandez E, Gastaldi P. Hip pain from the orthopeadic point of view. Eur J Radiol 2011; 81:3737-9. [PMID: 21893392 DOI: 10.1016/j.ejrad.2011.03.096] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/16/2011] [Accepted: 03/22/2011] [Indexed: 10/17/2022]
Abstract
The hip and its disorders represent a clinical, diagnostic and therapeutic challenge greater than any other joints. Clinical symptoms are usually non specific and provocative maneuvers are sometimes unreliable, pain might be referred even from other joints and many times accurate assessment need imaging techniques. New surgical options, especially the latest development of hip arthroscopy has open horizons for treating intraarticular disorders. In this review article we will review basic clinical assessment and what we need as orthopeadic surgeons from radiology.
Collapse
|
114
|
Gruer L, Bettcher D, Haw S, Fernandez E, Vichit-Vadakan N. O5-1 Smoke-free legislation: global reach, impact and remaining challenges. Br J Soc Med 2011. [DOI: 10.1136/jech.2011.142976b.38] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
115
|
Fernandez E. O5-1.3 From partial to comprehensive smoking bans: lessons from Spain for global tobacco control. Br J Soc Med 2011. [DOI: 10.1136/jech.2011.142976b.41] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
116
|
McCabe K, Shobeiri N, Beseau D, Adams M, Holden R, Shobeiri N, Adams M, Holden R, Maio T, McCabe K, Laverty K, Beseau D, Pang J, Jozefacki A, Shobeiri N, Holden R, Adams M, Salem S, Jankowski V, Passlick-Deetjen J, Peter M, Zidek W, Jankowski J, Riser B, Barreto F, Valaitis P, Cook C, White J, Drueke T, Holmes C, Massy Z, Mizobuchi M, Ogata H, Kumata C, Nakazawa A, Koiwa F, Kinugasa E, Akizawa T, Lopez I, Aguilera-Tejero E, Guerrero F, Pineda C, Raya AI, Peralta A, Rodriguez M, Ciceri P, Volpi E, Brenna I, Brancaccio D, Cozzolino M, Bozic M, deRoij J, Parisi E, Ruiz-Ortega M, Fernandez E, Valdivielso JM, Lee CT, Ng HY, Tsai YC, Yang YK, Niwa T, Adijiang A, Shimizu H, Nishijima F, Okamoto T, Kamata K, Naito S, Aoyama T, Tazaki H, Yamanaka N, Koenigshausen E, Ohlsson S, Woznowski M, Quack I, Potthoff SA, Rump LC, Sellin L, Maquigussa E, Pereira L, Arnoni C, Boim M, Lee KW, Jeong JY, Jang WI, Chung S, Choi DE, Na KR, Shin YT, Slabiak-Blaz N, Adamczak M, Ritz E, Wiecek A, Uz E, Uz B, Sahin Balcik O, Kaya A, Akdeniz D, Bavbek Ruzgaresen N, Uz E, Turgut FH, Bayrak R, Carlioglu A, Akcay A, Galichon P, Vittoz N, Cornaire E, Baugey E, Vandermeersch S, Verpont MC, Mesnard L, Xu-Dubois YC, Hertig A, Rondeau E, Kokeny G, Fekeshazy O, Fang L, Rosivall L, Mozes MM, Duggan K, Hodge G, Ha H, Chen J, Lee L, Tay C, Macdonald G, Wang PHM, Tamouza H, Chemouny J, Monsinjon E, Tiwari M, Vende F, Vrtovsnik F, Camara NO, Benhamou M, Monteiro RC, Moura IC, Rigothier C, Saleem M, Ripoche J, Mathieson P, Combe C, Welsh G, Duwel A, Munoz-Felix JM, Lopez-Novoa JM, Martinez-Salgado C, Koutroutsos K, Kassimatis T, Nomikos A, Giannopoulou I, Papadakis J, Nakopoulou L, Nakamichi T, Mori T, Sato T, Sato H, Ito S, Neudecker S, Heilmann M, Kramer P, Wolf I, Sticht C, Schock-Kusch D, Gubhaju L, Kriz W, Bertram JF, Schad LR, Gretz N, Munoz-Felix JM, Fuentes-Calvo I, Lopez-Novoa JM, Martinez-Salgado C, Kimura T, Takabatake Y, Takahashi A, Kaimori JY, Matsui I, Namba T, Kitamura H, Niimura F, Matsusaka T, Soga T, Rakugi H, Isaka Y, Shin SJ, Kim KS, Kim WK, Rampanelli E, Teske G, Leemans J, Florquin S, Small D, Bennett N, Roy S, Gobe G, Blazquez-Medela AM, Garcia-Sanchez O, Lopez-Hernandez FJ, Lopez-Novoa JM, Martinez-Salgado C, Deibel A, Cheng J, Warner G, Knudsen B, Gray C, Lien K, Juskewitch J, Grande J, Wang N, Wang X, Zeng M, Sun B, Xing C, Zhao X, Xiong M, Yang J, Cao K, Priante G, Musacchio E, Sartori L, Valvason C, Baggio B, Pitlovanciv EDON, Reis LA, Pessoa EA, Teixeira L, Borges FT, Simoes MJ, Schor N, Munoz-Felix JM, Duwel A, Lopez-Novoa JM, Martinez-Salgado C, Doustar Y, Mohajeri D, Smirnov AV, Kucher AG, Ivanova GT, Berseneva ON, Parastaeva MM, Zarajsky MI, Saburova IJ, Kaukov IG, Koppe L, Fouque D, Dugenet Y, Soulage C, Wan J, Yang X, Cui J, Zou Z. Experimental pathology. Clin Kidney J 2011. [DOI: 10.1093/ndtplus/4.s2.52] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
117
|
Rodriguez H, Espinoza-Navarro O, Silva I, Quiroz P, Arriaza C, Sanchez C, Vallejos R, Castro ME, Arias M, Jimenez L, Fernandez E. Histological Description of the Interaction Between Muscle Fibers and Connective Tissue of the Fascia of the Human Trapezius Muscle. INT J MORPHOL 2011. [DOI: 10.4067/s0717-95022011000100049] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
118
|
Fernandez E, Perez R, Hernandez A, Tejada P, Arteta M, Ramos JT. Factors and Mechanisms for Pharmacokinetic Differences between Pediatric Population and Adults. Pharmaceutics 2011; 3:53-72. [PMID: 24310425 PMCID: PMC3857037 DOI: 10.3390/pharmaceutics3010053] [Citation(s) in RCA: 187] [Impact Index Per Article: 14.4] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/16/2010] [Accepted: 01/28/2011] [Indexed: 12/14/2022] Open
Abstract
Many physiologic differences between children and adults may result in age-related changes in pharmacokinetics and pharmacodynamics. Factors such as gastric pH and emptying time, intestinal transit time, immaturity of secretion and activity of bile and pancreatic fluid among other factors determine the oral bioavailability of pediatric and adult populations. Anatomical, physiological and biochemical characteristics in children also affect the bioavailability of other routes of administration. Key factors explaining differences in drug distribution between the pediatric population and adults are membrane permeability, plasma protein binding and total body water. As far as drug metabolism is concerned, important differences have been found in the pediatric population compared with adults both for phase I and phase II metabolic enzymes. Immaturity of glomerular filtration, renal tubular secretion and tubular reabsorption at birth and their maturation determine the different excretion of drugs in the pediatric population compared to adults.
Collapse
|
119
|
Fu M, Martinez-Sanchez JM, Agudo A, Pascual JA, Borras JM, Samet JM, Fernandez E. Association Between Time to First Cigarette After Waking Up and Salivary Cotinine Concentration. Nicotine Tob Res 2011; 13:168-72. [DOI: 10.1093/ntr/ntq232] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
120
|
Fernandez E, Lauretti L, Tufo T, D’Ercole M, Ciampini A, Doglietto F. End-to-side nerve neurorrhaphy: critical appraisal of experimental and clinical data. HOW TO IMPROVE THE RESULTS OF PERIPHERAL NERVE SURGERY 2011; 100:77-84. [DOI: 10.1007/978-3-211-72958-8_17] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
|
121
|
Dalen H, Thorstensen A, Romundstad PR, Aase SA, Stoylen A, Vatten L, Coll B, Feinstein SB, Fernandez E, Betriu A, Nambi V, Zamorano JL, Hristova K, Katova TZ, D'hooge J, Sandgaard N, Diederichsen AC, Moller JE, Thayssen P, Vlahovic-Stipac A, Otasevic P, Stankovic I, Putnikovic B, Neskovic AN, Chrzanowski L, Kasprzak JD, Busz-Papiez B, Wita K, Gasior Z, Kukulski T, Tomaszewski A, Mizia-Stec K, Wojciechowska C, Plonska-Gosciniak E, Lemarie J, Valla M, Huttin O, Sellal JM, Oliver C, Christophe C, Marcon O, Schwartz J, Popovic B, Selton-Suty C, Trifunovic D, Sobic-Saranovic D, Ostojic M, Stankovic S, Vujisic-Tesic B, Petrovic M, Nedeljkovic I, Banovic M, Boricic M, Draganic G, Kiviniemi TO, Ylitalo A, Karjalainen PP, Saraste A, Mikkelsson J, Airaksinen KEJ, Bobescu E, Radoi M, Datcu G, Dobreanu D, Doka BF. Moderated Posters session IV: Viability and recovery of systolic function. The echo approach * Friday 10 December 2010, 15:30-16:30. EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY 2010. [DOI: 10.1093/ejechocard/jeq145] [Citation(s) in RCA: 18] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
122
|
Fernandez E, Orrell D, Snell C, Chassagnole C. 565 The Virtual Tumour, a predictive simulation platform to optimize anti-cancer drug scheduling and combination. EJC Suppl 2010. [DOI: 10.1016/s1359-6349(10)72272-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
123
|
de Francisco ALM, Fernandez E, Cruz JJ, Casas MT, Gómez-Gerique J, León A, Cava F, Bedini JL, Enguix A, Ripoll E, Borque LA, Fernandez A, Arias M. Under-recognized renal insufficiency in hospitalized patients: implications for care. Eur J Intern Med 2010; 21:327-32. [PMID: 20603046 DOI: 10.1016/j.ejim.2010.04.011] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2010] [Revised: 04/15/2010] [Accepted: 04/27/2010] [Indexed: 11/29/2022]
Abstract
BACKGROUND The consequences of undetected low glomerular filtration rate (GFR) are important in hospitalized patients who receive potentially nephrotoxic drugs or undergo major surgery. This study estimated the prevalence of estimated GFR (eGFR) <60mL/min/1.73m(2) in hospitalized patients. METHODS This cross-sectional descriptive study included 14,658 adults hospitalized at 10 centers in Spain. Serum samples were analyzed for hemoglobin, creatinine, albumin and urea nitrogen. eGFR was estimated using Modification of Diet in Renal Disease (MDRD) 4 or MDRD IDMS, and MDRD 6 when serum albumin and BUN were included (n=8611). Individuals were classified as having GFR>or=60mL/min/1.73m(2), stages 3, 4 and 5 (GFR 30-59, 15-29 and <15mL/min/1.73m(2), respectively). Additionally, stages 3a and 3b (GFR 45-59 and 30-44mL/min/1.73m(2), respectively) were assessed. RESULTS MDRD 4 eGFR showed that 28.3% of patients had renal insufficiency stages 3-5 and 14.2% had stages 3b, 4 or 5, which represents important-severe renal deterioration. Forty-three percent of patients with stages 3-5 had hemoglobin <or=11g/dL, compared with 27.9% of patients with eGFR>or=60mL/min/1.73m(2). A good correlation was observed between eGFR MDRD 4 and MDRD 6. CONCLUSIONS A high percentage of hospitalized patients in Spain have deteriorated renal function stages 3-5. Using eGFR equations to assess eGFR could identify more hospitalized patients with renal insufficiency, potentially leading to improved care.
Collapse
|
124
|
Martinez-Fresno M, Suela J, Calvente M, Eibes P, Gomez A, Fernandez E. P38 Aneuploidy screening in single cells using microarray comparative genomic hybridization for preimplantational genetic diagnosis purposes. Reprod Biomed Online 2010. [DOI: 10.1016/s1472-6483(10)62354-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
125
|
Cerda JC, Sanchez V, Perez F, Fernandez E. Use of the FAST HUG checklist in Mexican critically ill patients. Crit Care 2010. [PMCID: PMC2934369 DOI: 10.1186/cc8689] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|